Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Pathogenesis and Immunity

Introduction of Virulence Markers in PB2 of Pandemic Swine-Origin Influenza Virus Does Not Result in Enhanced Virulence or Transmission

Sander Herfst, Salin Chutinimitkul, Jianqiang Ye, Emmie de Wit, Vincent J. Munster, Eefje J. A. Schrauwen, Theo M. Bestebroer, Marcel Jonges, Adam Meijer, Marion Koopmans, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus, Daniel R. Perez, Ron A. M. Fouchier
Sander Herfst
1National Influenza Center and Department of Virology, Erasmus Medical Center, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salin Chutinimitkul
1National Influenza Center and Department of Virology, Erasmus Medical Center, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianqiang Ye
2Department of Veterinary Medicine, University of Maryland, College Park, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmie de Wit
1National Influenza Center and Department of Virology, Erasmus Medical Center, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent J. Munster
1National Influenza Center and Department of Virology, Erasmus Medical Center, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eefje J. A. Schrauwen
1National Influenza Center and Department of Virology, Erasmus Medical Center, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theo M. Bestebroer
1National Influenza Center and Department of Virology, Erasmus Medical Center, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcel Jonges
3National Institute for Public Health and the Environment, Laboratory for Infectious Diseases and Screening, Bilthoven, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Meijer
3National Institute for Public Health and the Environment, Laboratory for Infectious Diseases and Screening, Bilthoven, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marion Koopmans
3National Institute for Public Health and the Environment, Laboratory for Infectious Diseases and Screening, Bilthoven, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guus F. Rimmelzwaan
1National Influenza Center and Department of Virology, Erasmus Medical Center, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert D. M. E. Osterhaus
1National Influenza Center and Department of Virology, Erasmus Medical Center, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel R. Perez
2Department of Veterinary Medicine, University of Maryland, College Park, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ron A. M. Fouchier
1National Influenza Center and Department of Virology, Erasmus Medical Center, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: r.fouchier@erasmusmc.nl
DOI: 10.1128/JVI.02634-09
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Activity of the NL602 polymerase complex with wild type (wt) PB2, PB2-E627K, PB2-E677G, and PB2-D701N in minigenome assays. Firefly luciferase was expressed from a synthetic viral RNA when the influenza virus polymerase complex was present. The luminescence of the firefly luciferase reporter was standardized using a plasmid constitutively expressing Renilla luciferase protein to correct for differences in transfection efficiencies and sample processing. Relative luminescence was calculated as the percent relative light units (firefly luciferase/Renilla luciferase), and the fold difference in reporter protein expression was calculated with the wild-type polymerase complex as a reference. Averages and standard deviations from two independent experiments performed in duplicate are shown. Neg, negative control.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Replication kinetics of NL602, NL602/PB2-627K, NL602/PB2-677G, and NL602/PB2-701N viruses in MDCK cells. MDCK cells were inoculated with 0.01 TCID50/cell of the NL602 (closed circles), NL602/PB2-627K (open circles), NL602/PB2-677G (closed squares), and NL602/PB2-701N (open squares) viruses, and supernatant samples were harvested 6, 12, 24, and 48 h later. The supernatant samples were titrated in MDCK cells. Geometric mean titers and standard deviations were calculated from two independent experiments.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Weight loss of BALB/c mice inoculated with NL602, NL602/PB2-627K, NL602/PB2-677G, and NL602/PB2-701N viruses. Mean bodyweights and standard deviations were calculated as percentages of bodyweight compared to bodyweight at the time of inoculation for each group inoculated with NL602 (closed circles), NL602/PB2-627K (open circles), NL602/PB2-677G (closed squares), and NL602/PB2-701N (open squares) viruses.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Weight loss of ferrets inoculated with NL602, NL602/PB2-627K, NL602/PB2-677G, and NL602/PB2-701N viruses. Bodyweight is depicted as percentage of bodyweight at time of inoculation. Data are shown for individual animals until the animals were euthanized at 3 or 7 days p.i.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Virus shedding from the upper respiratory tract of ferrets inoculated with NL602, NL602/PB2-627K, NL602/PB2-677G, and NL602/PB2-701N viruses. Virus detection in throat swabs (A) and nose swabs (B) is indicated for NL602 (black bars), NL602/PB2-627K (white bars), NL602/PB2-677G (dark-gray bars), and NL602/PB2-701N (light-gray bars). Geometric mean titers for positive samples are displayed, and the error bars indicate the standard deviations. The lower limits of detection are indicated by the dotted lines.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Transmission of NL602, NL602/PB2-627K, NL602/PB2-677G, and NL602/PB2-701N viruses by aerosol or respiratory droplets in ferrets. Virus titers in throat (black bars) and nose (white bars) swabs are displayed for inoculated (A to D) and exposed (E to H) ferrets. The geometric mean titers of positive samples are displayed, and the error bars indicate the standard deviations. The number of positive contact animals per day is depicted. The asterisk indicates that one ferret was negative for virus shedding but seroconverted to influenza A virus nucleoprotein in the course of the experiment. The lower limits of detection are indicated by the dotted lines.

Tables

  • Figures
  • TABLE 1.

    Virus titers in the lungs of BALB/c mice inoculated with NL602, NL602/PB2-627K, NL602/PB2-677G, and NL602/PB2-701N viruses

    Time after inoculation (days)Virus titer (log10 TCID50/g of tissue)a
    NL602NL602/PB2-627KNL602/PB2-677GNL602/PB2-701N
    36.0 ± 0.36.4 ± 0.56.5 ± 0.46.0 ± 0.3
    64.9 ± 0.34.9 ± 0.25.6 ± 0.85.3 ± 0.4
    • ↵ a Geometric mean titers ± standard deviations are given.

  • TABLE 2.

    Virus titers in the respiratory tracts of ferrets inoculated with NL602, NL602/PB2-627K, NL602/PB2-677G, and NL602/PB2-701N viruses

    TissueVirus titer (log10 TCID50/g tissue)a
    3 days p.i.7 days p.i.
    NL602NL602 627KNL602 677GNL602 701NNL602NL602 627KNL602 677GNL602 701N
    NT6.9 ± 0.3 (3/3)7.2 ± 0.6 (3/3)6.8 ± 0.5 (3/3)6.7 ± 0.6 (3/3)4.4 ± 0.7 (2/3)ND6.8 (1/3)4.9 ± 1.3 (3/3)
    Trachea5.0 ± 0.7 (3/3)4.4 ± 1.0 (3/3)5.3 ± 0.5 (2/3)5.1 ± 1.0 (3/3)2.4 (1/3)NDND2.1 (1/3)
    Lung5.6 ± 0.9 (3/3)5.4 ± 0.7 (2/3)4.8 ± 0.3 (2/3)4.9 ± 1.1 (3/3)1.5 (1/3)NDNDND
    • ↵ a Geometric mean titers of positive samples ± standard deviations are given, and the numbers of positive animals are indicated in parentheses. ND, not detected. The detection levels for nasal turbinates (NT), trachea, and lung were <1.5, <1.5, and <1 log10 TCID50/g tissue, respectively.

PreviousNext
Back to top
Download PDF
Citation Tools
Introduction of Virulence Markers in PB2 of Pandemic Swine-Origin Influenza Virus Does Not Result in Enhanced Virulence or Transmission
Sander Herfst, Salin Chutinimitkul, Jianqiang Ye, Emmie de Wit, Vincent J. Munster, Eefje J. A. Schrauwen, Theo M. Bestebroer, Marcel Jonges, Adam Meijer, Marion Koopmans, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus, Daniel R. Perez, Ron A. M. Fouchier
Journal of Virology Mar 2010, 84 (8) 3752-3758; DOI: 10.1128/JVI.02634-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Introduction of Virulence Markers in PB2 of Pandemic Swine-Origin Influenza Virus Does Not Result in Enhanced Virulence or Transmission
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Introduction of Virulence Markers in PB2 of Pandemic Swine-Origin Influenza Virus Does Not Result in Enhanced Virulence or Transmission
Sander Herfst, Salin Chutinimitkul, Jianqiang Ye, Emmie de Wit, Vincent J. Munster, Eefje J. A. Schrauwen, Theo M. Bestebroer, Marcel Jonges, Adam Meijer, Marion Koopmans, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus, Daniel R. Perez, Ron A. M. Fouchier
Journal of Virology Mar 2010, 84 (8) 3752-3758; DOI: 10.1128/JVI.02634-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

amino acid substitution
Influenza A Virus, H1N1 Subtype
Mutation, Missense
Orthomyxoviridae Infections
Viral Proteins
virulence factors

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514